Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. 1994

D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
Academic Department of Haematology and Cytogenetics, Institute of Cancer Research, London, UK.

The translocation t(11;14)(q13;q32) occurs in about 15% of patients with splenic lymphoma with villous lymphocytes (SLVL) or the closely related disorder lymphoplasmacytic lymphoma (LPL). To characterize the nature and frequency of rearrangements of the BCL-1 locus in SLVL/LPL and to document the effect of these genetic alterations on the expression of the cyclin D1 gene, we analyzed 22 cases of SLVL/LPL with defined cytogenetic abnormalities by both conventional electrophoresis (CE) and pulse-field gel electrophoresis (PFGE) and by Northern blotting. Four SLVL/LPL cases showed rearrangement of the BCL-1 locus. In two cases with t(11;14)(q13;q32), different breakpoints were identified; one mapped adjacent to the major translocation cluster (MTC) and the other within a 28-kb region telomeric of it. In a third case of SLVL with no cytogenetic abnormality of 11q13, a novel breakpoint approximately 100 kb centromeric of MTC was detected by PFGE. The fourth case, which had a normal karyotype, demonstrated rearrangement with a BCL-1 probe immediately telomeric of MTC. This case may have had a small deletion of 0.5 kb from within the BCL-1 locus. No rearrangement of the BCL-1 locus or within the cyclin D1 gene was detected by CE or PFGE in any of the remaining 18 SLVL/LPL samples. Northern blot analysis showed expression of a normal-sized cyclin D1 transcript in the two SLVL/LPL cases with t(11;14)(q13;q32). In cases that lacked a cytogenetically demonstrable t(11;14) translocation, no cyclin D1 transcript was detected. Analysis of the BCL-1 locus was also performed in three other cases of B-cell disorders with t(11;14)(q13;q32) detected cytogenetically. Two cases were analyzed by Southern blot and showed rearrangement of the BCL-1 locus. Expression of high-level normal-sized and/or truncated cyclin D1 transcript was also detected in these cases. These data show the importance of PFGE in the detection of rearrangements in the BCL-1 locus and show further the complexity of rearrangements in this locus.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002880 Chromosomes, Human, Pair 11 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 11
D002883 Chromosomes, Human, Pair 14 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 14
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013160 Splenic Neoplasms Tumors or cancer of the SPLEEN. Cancer of Spleen,Spleen Cancer,Cancer of the Spleen,Neoplasms, Splenic,Spleen Neoplasms,Splenic Cancer,Cancer, Spleen,Cancer, Splenic,Cancers, Spleen,Cancers, Splenic,Neoplasm, Spleen,Neoplasm, Splenic,Neoplasms, Spleen,Spleen Cancers,Spleen Neoplasm,Splenic Cancers,Splenic Neoplasm

Related Publications

D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
September 1993, Cancer research,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
January 2008, Indian journal of pathology & microbiology,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
January 1997, Annals of oncology : official journal of the European Society for Medical Oncology,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
January 1994, Annales de medecine interne,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
June 1995, Journal of clinical pathology,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
January 1994, Srpski arhiv za celokupno lekarstvo,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
July 1996, The Journal of pathology,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
April 1999, Seminars in hematology,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
December 1994, Blood,
D Jadayel, and E Matutes, and M J Dyer, and V Brito-Babapulle, and M T Khohkar, and D Oscier, and D Catovsky
October 2003, British journal of haematology,
Copied contents to your clipboard!